Umbrella Trials & Combination Therapy as a Route to Accelerating Commercialisation of CNS Therapeutics
Time: 4:00 pm
day: Conference Day Two
Details:
- How umbrella trials streamline timelines and reduce duplication – key benefits for CNS programs facing long development cycles
- Leveraging umbrella trials to test multiple indications and mechanisms, supporting differentiated value propositions and early payer engagement
- How umbrella frameworks allow iterative learning without restarting full trials, enabling earlier, more confident steps toward commercialization
